Organization
RheumatologySA, Adelaide, Australia
1 abstract
Abstract
ASSESSMENT OF S95011 (OSE-127, LUSVERTIKIMAB), AN ANTI-INTERLEUKIN 7 RECEPTOR MONOCLONAL ANTIBODY, IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME: AN INTERNATIONAL MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2A STUDYOrg: RheumatologySA, Adelaide, Australia, Vita Verum Medical Private Practice, Skékesfehervar, Hungary, Institut de Recherches Internationales Servier, Suresnes, France,